BOXL vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

BOXL

59.1
AI Score
VS
BOXL Wins

UTI

46.2
AI Score

Investment Advisor Scores

BOXL

59score
Recommendation
HOLD

UTI

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BOXL UTI Winner
Forward P/E 12.0482 27.248 BOXL
PEG Ratio 0 1.8142 Tie
Revenue Growth -16.0% 7.2% UTI
Earnings Growth 337.6% -78.9% BOXL
Tradestie Score 59.1/100 46.2/100 BOXL
Profit Margin -21.0% 3.9% UTI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

BOXL 1M: -43.6% · 3M: -21.7% UTI 1M: +3.9% · 3M: -43.9%

Current Technical Phase

BOXL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 33.4 · Price: $2.78

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.5 · Price: $21.21

Fundamentals Snapshot

Metric BOXL UTI
Market Cap — —
Forward P/E 0.0 28.3
Trailing P/E — 33.8
Revenue (TTM) — —
Revenue Growth -0.2% 0.1%
Gross Margin 0.3% 0.6%
Operating Margin 0.0% 0.0%
EPS -142.19 0.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BOXL is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.